Stay updated on Anti-PD-1 Antibody With HD IL-2 in Metastatic Melanoma Clinical Trial

Sign up to get notified when there's something new on the Anti-PD-1 Antibody With HD IL-2 in Metastatic Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Anti-PD-1 Antibody With HD IL-2 in Metastatic Melanoma Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The metastatic melanoma trial record is displayed, including its terminated status, eligibility criteria, treatment plan, outcomes, and study results information.
    Difference
    52%
    Check dated 2026-11-07T14:52:34.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The footer’s site revision identifier changed from v3.7.2 to v3.8.0 while the page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-31T15:22:09.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    A site-wide banner announces NIH’s transition from the term “Artificial Intelligence” to “Super Intelligence.” The clinical trial record remains inaccessible, displaying a 403 error.
    Difference
    1%
    Check dated 2026-10-24T17:37:08.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The footer’s site revision identifier changed from v3.7.1 to v3.7.2 while the page continued to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-17T17:07:11.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The site footer revision label changes from v3.7.0 to v3.7.1 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-10T18:06:30.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    403 Forbidden page is now shown, replacing the study record content. The main study details become inaccessible on this page, limiting user access to information about the trial.
    Difference
    19%
    Check dated 2026-09-19T19:22:12.000Z thumbnail image

Stay in the know with updates to Anti-PD-1 Antibody With HD IL-2 in Metastatic Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Anti-PD-1 Antibody With HD IL-2 in Metastatic Melanoma Clinical Trial page.